Westerberg & Partners‘ practice frequently assists pharma clients with product launches within the Swedish market. In addition to the group’s extensive contentious IP capability, it also regularly advises on research and development agreements. ’Excellent‘ patent litigator Jonas Löfgren leads the team with his deep regulatory expertise, with particular emphasis on market access, and pricing and reimbursement matters. Wendela Hårdemark is well-versed in contentious matters concerning license agreements. Ludvig Holm regularly acts in patent and trade mark disputes, while Jonas Westerberg is noted for his vast knowledge of IP litigation and arbitration.
Testimonials
Collated independently by Legal 500 research team.
‘Jonas Löfgren is very experienced, with great knowledge of the Swedish market. He is very responsive and provides constant great legal support and practical solutions.’
‘First rate service. Jonas Löfgren in particular is excellent.’
‘Jonas Löfgren has hard-edged experience and is practical on very technical issues.’
Key clients
- Alnylam Pharmaceuticals
- GlaxoSmithKline
- Novartis
- Dr Wolff Group
- Karo Healthcare
- Illumina, Inc
Work highlights
- Acted for Illumina in a multitude of parallel patent proceedings regarding the infringement and validity of patents in the DNA sequencing field.
- Advised Dr. Wolf Group on the market access in Sweden of its first medicinal product, Axhidrox.
Practice head
The lawyer(s) leading their teams.
Jonas Löfgren